The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says
In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs
Intramural Funding To Decrease, R01s Increase, Klausner Says
Harlow, Abeloff To Chair BSC Subcommittees; Livingston To Head Extramural Advisors
New Structure Of Divisions Outlined
“Flat” Administrative Structure To Include Resource Teams
Next Bypass Budget: Slim, Trim, Modest


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









